In compliance with that, the study performed by Schultheis et al
Time to Results: Noticeable Appetite Reduction: GLP-1s (semaglutide, tirzepatide): 1-2 weeks Phentermine: 1-3 days Phentermine-topiramate: 1-2 weeks Naltrexone-bupropion: 4-8 weeks Orlistat: Doesnt reduce appetite Measurable Weight Loss: Tirzepatide: 5-8% by week 20, 15-22% by week 72 Semaglutide: 5-7% by week 20, 10-15% by week 68 Phentermine-topiramate: 5-6% by week 28 Others: 3-5% by week 24-28 GLP-1s produce steady, sustained weight loss over 16-20 months
A Dietitian's Framework GLP-1 medications work partly by slowing how quickly food leaves your stomach, which helps you feel full longer and keeps blood sugar from spiking after meals
Licensed healthcare providers may also prescribe Mounjaro off-label for weight loss when medically appropriate, based on individual clinical evaluation
Erythropoietic Protoporphyria (EPP) Melanotan-1 Melanotan-1 (afamelanotide/Scenesse) is the only EMA-approved treatment for EPP, with Phase 3 RCT data showing increased pain-free sun exposure and improved quality of life Vitiligo Adjunct Therapy Melanotan-1 Small RCT data shows faster and deeper repigmentation when afamelanotide implants are combined with NB-UVB phototherapy compared to phototherapy alone Photoprotection Research Melanotan-1 Melanotan-1 enhances eumelanin production and DNA repair mechanisms with a favorable safety profile established across multiple clinical trials Melanocortin Receptor Pharmacology Melanotan-2 Melanotan-2 nonselective receptor profile makes it a useful research tool for studying MC1R through MC5R signaling pathways Sexual Dysfunction Research Melanotan-2 Melanotan-2 MC4R activation produces erectogenic effects
EMBO J (1995) 14(9):200513
